GSK Insider Purchases Signal Confidence in Company
PremiumCompany AnnouncementsGSK Insider Purchases Signal Confidence in Company
11d ago
GSK reaffirms 2024 core EPS growth view 10%-12%
Premium
The Fly
GSK reaffirms 2024 core EPS growth view 10%-12%
11d ago
GSK reports Q3 core EPS 49.7p, up 5% at CER
Premium
The Fly
GSK reports Q3 core EPS 49.7p, up 5% at CER
11d ago
GSK Pharma put volume heavy and directionally bearish
PremiumThe FlyGSK Pharma put volume heavy and directionally bearish
16d ago
GSK reports preliminary data for AREXVY
Premium
The Fly
GSK reports preliminary data for AREXVY
17d ago
GSK’s Arexvy Vaccine Shows Promise for Broader Use
Premium
Company Announcements
GSK’s Arexvy Vaccine Shows Promise for Broader Use
17d ago
GSK Executives Acquire Shares Following Dividend Reinvestment
PremiumCompany AnnouncementsGSK Executives Acquire Shares Following Dividend Reinvestment
25d ago
ViiV Healthcare shares presentation on data for Apretude for HIV PrEP
Premium
The Fly
ViiV Healthcare shares presentation on data for Apretude for HIV PrEP
25d ago
GSK announces U.S. FDA accepted NDA for gepotidacin
Premium
The Fly
GSK announces U.S. FDA accepted NDA for gepotidacin
25d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100